Journal of Drug Abuse Open Access

  • ISSN: 2471-853X
  • Journal h-index: 10
  • Journal CiteScore: 1.81
  • Journal Impact Factor: 1.92
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Articles published in Journal of Drug Abuse have been cited by esteemed scholars and scientists all around the world. Journal of Drug Abuse has got h-index 10, which means every article in Journal of Drug Abuse has got 10 average citations.

Following are the list of articles that have cited the articles published in Journal of Drug Abuse.

  2022 2021 2020 2019 2018 2017 2016

Total published articles

65 62 34 13 12 26 32

Research, Review articles and Editorials

9 10 8 2 4 8 2

Research communications, Review communications, Editorial communications, Case reports and Commentary

56 52 26 10 8 18 30

Conference proceedings

0 0 0 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

77 70 58 58 39 31 14
Journal total citations count 362
Journal impact factor 1.92
Journal 5 years impact factor 1.41
Journal cite score 1.81
Journal h-index 10
Important citations

Robertson M. The recognition and management of delirium superimposed on dementia. Working with Older People. 2021 Jun 18.

Ahmadi J. Psychiatric Disorders Induced by Abuse of Non-Addictive Substances: An Original Finding. Europe. 2008;1:3.

Primatanti A. Methylphenidate augmentation during antidepressant treatment for depression in HIV: a case report. InIOP Conference Series: Materials Science and Engineering 2018 Nov 1 (Vol. 434, No. 1, p. 012331). IOP Publishing.

YANG L, MA X, CAO H, SU B, XU J, CAI Y. The injury, reversibility and intervention strategies of inhibitory control for methamphetamine users. Advances in Psychological Science. 2017 Oct 15;25(10):1769.

Ahmadi J, Sahraian A, Biuseh M. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving. Trials. 2019 Dec;20(1):1-7.

Ahmadi J, Dastgheib SA, Pridmore S. Buprenorphine in the treatment of severe major depression with severe suicidal temptations. Global journal of addiction & rehabilitation medicine. 2017;1(5):1-3.

Ahmadi J. Misuse of Zolpidem to get high: A distinguished mystery. Neuropsychiatry. 2016;6(2):64-7.

Ahmadi J. Fast treatment of methamphetamine related anxiety and depressive disorders: a novel approach. Journal of Addiction Medicine and Therapeutic Science. 2016 Mar 8;2(1):1-3.

Ahmadi J, Jahromi LR. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial. Trials. 2017 Dec;18(1):1-8.

Pacher CJ. Social Workers' Perceptions of Barriers to Substance Abuse Treatment in Mississippi (Doctoral dissertation, Walden University).

Caffino L, Mottarlini F, VanReijmersdal B, Telese F, Verheij MM, Fumagalli F, Homberg JR. The role of the serotonin transporter in prefrontal cortex glutamatergic signaling following.

Wickens MM. Deletion of Glutamate Receptor Trafficking Proteins in the Medial Prefrontal Cortex and Their Sex-specific Effects on Cocaine Addiction. Temple University; 2020.

Knackstedt LA, Schwendt M. Extinction vs. Abstinence: A Review of the Molecular and Circuit Consequences of Post-Cocaine Extinction and Abstinence.

YANG PY, JIANG HF. Research progress in cue-reactivity of addictive substance and its neural mechanism. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE). 2021 Mar 28;41(3):376.

Hofford RS, Euston TJ, Wilson RS, Meckel KR, Peck EG, Godino A, Landry JA, Calipari ES, Lam TT, Kiraly DD. Granulocyte-Colony Stimulating Factor reduces cocaine-seeking and downregulates glutamatergic synaptic proteins in medial prefrontal cortex. Journal of Neuroscience. 2021 Feb 17;41(7):1553-65.

Caffino L, Mottarlini F, Van Reijmersdal B, Telese F, Verheij MM, Fumagalli F, Homberg JR. The role of the serotonin transporter in prefrontal cortex glutamatergic signaling following short?and long?access cocaine self?administration. Addiction biology. 2021 Mar;26(2):e12896.

Ploense KL, Li X, Baker-Andresen D, Carr AE, Woodward N, Bagley J, Szumlinski KK, Bredy TW, Kippin TE. Prolonged-access to cocaine induces distinct Homer2 DNA methylation, hydroxymethylation, and transcriptional profiles in the dorsomedial prefrontal cortex of Male Sprague-Dawley rats. Neuropharmacology. 2018 Dec 1;143:299-305.

Wickens MM, Deutschmann AU, McGrath AG, Parikh V, Briand LA. Glutamate receptor interacting protein acts within the prefrontal cortex to blunt cocaine seeking. Neuropharmacology. 2019 Oct 1;157:107672.

Abel JM, Nesil T, Bakhti-Suroosh A, Grant PA, Lynch WJ. Mechanisms underlying the efficacy of exercise as an intervention for cocaine relapse: a focus on mGlu5 in the dorsal medial prefrontal cortex. Psychopharmacology. 2019 Jul;236(7):2155-71.

Ploense KL, Vieira P, Bubalo L, Olivarria G, Carr AE, Szumlinski KK, Kippin TE. Contributions of prolonged contingent and non-contingent cocaine exposure to escalation of cocaine intake and glutamatergic gene expression. Psychopharmacology. 2018 May;235(5):1347-59.